GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $64.82 $75.66 Friday, 19th Apr 2024 CYTK stock ended at $67.55. This is 0.82% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $64.82 to a day high of $67.80.
90 days $61.33 $84.92
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
2021-08-12 $32.60 $32.80 $31.82 $32.43 462 119
2021-08-11 $31.44 $32.71 $31.33 $32.53 500 230
2021-08-10 $32.21 $32.21 $31.11 $31.93 865 680
2021-08-09 $31.59 $32.97 $31.31 $31.89 1 402 653
2021-08-06 $29.51 $32.49 $29.17 $31.82 1 113 491
2021-08-05 $29.53 $31.00 $28.66 $30.24 890 846
2021-08-04 $28.84 $29.95 $28.84 $29.51 925 691
2021-08-03 $28.83 $29.22 $28.24 $28.83 1 534 697
2021-08-02 $29.67 $30.14 $27.81 $28.77 1 587 787
2021-07-30 $28.94 $29.92 $28.84 $29.68 782 532
2021-07-29 $29.35 $29.73 $29.00 $29.36 453 812
2021-07-28 $28.12 $29.33 $27.82 $29.06 1 091 182
2021-07-27 $27.95 $28.63 $27.00 $28.11 2 015 825
2021-07-26 $29.15 $29.40 $27.93 $28.20 1 471 216
2021-07-23 $30.51 $31.32 $28.94 $29.04 4 079 438
2021-07-22 $30.05 $30.59 $29.13 $30.10 5 840 256
2021-07-21 $28.56 $30.14 $27.80 $29.28 9 723 905
2021-07-20 $28.61 $31.19 $27.26 $29.18 8 023 252
2021-07-19 $27.91 $31.41 $26.69 $27.00 40 016 057
2021-07-16 $19.49 $19.87 $19.04 $19.23 621 033
2021-07-15 $18.35 $19.89 $18.35 $19.32 1 096 948
2021-07-14 $18.79 $18.80 $17.72 $18.54 965 331
2021-07-13 $19.14 $19.45 $18.66 $18.79 1 019 086
2021-07-12 $19.66 $20.00 $19.14 $19.25 702 958
2021-07-09 $19.80 $19.93 $19.30 $19.59 295 997
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT